名字意味着什么？神经元中间丝包涵体病（NIFID）、额颞叶痴呆-中间丝型（FTLD-IF）还是额颞叶痴呆-肉瘤融合基因型（FTLD-FUS）？ - Suppr | 超能文献

What's in a name? Neuronal intermediate filament inclusion disease (NIFID), frontotemporal lobar degeneration-intermediate filament (FTLD-IF) or frontotemporal lobar degeneration-fused in sarcoma (FTLD-FUS)?

作者信息

Menon R, Baborie A, Jaros E, Mann D M A, Ray P S, Larner A J

出版信息

J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1412-4. doi: 10.1136/jnnp.2010.220947. Epub 2010 Nov 8.

DOI:10.1136/jnnp.2010.220947

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

What's in a name? Neuronal intermediate filament inclusion disease (NIFID), frontotemporal lobar degeneration-intermediate filament (FTLD-IF) or frontotemporal lobar degeneration-fused in sarcoma (FTLD-FUS)?名字意味着什么？神经元中间丝包涵体病（NIFID）、额颞叶痴呆-中间丝型（FTLD-IF）还是额颞叶痴呆-肉瘤融合基因型（FTLD-FUS）？

J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1412-4. doi: 10.1136/jnnp.2010.220947. Epub 2010 Nov 8.

2

FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathy.FUS 免疫胶体金标记 TEM 分析神经元细胞内包涵体：伴有 FUS 蛋白病的额颞叶退行性变。

J Mol Neurosci. 2011 Nov;45(3):409-21. doi: 10.1007/s12031-011-9549-8. Epub 2011 May 21.

3

Phenotypic variability within the inclusion body spectrum of basophilic inclusion body disease and neuronal intermediate filament inclusion disease in frontotemporal lobar degenerations with FUS-positive inclusions.在伴有 FUS 阳性包涵体的额颞叶变性中，嗜碱性包涵体病和神经元中间丝包涵体病的包涵体谱内的表型变异性。

J Neuropathol Exp Neurol. 2012 Sep;71(9):795-805. doi: 10.1097/NEN.0b013e318266efb1.

4

A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.融合基因阳性肉瘤病的临床、病理、生化及遗传学对比研究。

Brain. 2011 Sep;134(Pt 9):2548-64. doi: 10.1093/brain/awr160. Epub 2011 Jul 12.

5

Pathological features of FTLD-FUS in a Japanese population: analyses of nine cases.日本人群中 FTLD-FUS 的病理学特征：9 例病例分析。

J Neurol Sci. 2013 Dec 15;335(1-2):89-95. doi: 10.1016/j.jns.2013.08.035. Epub 2013 Sep 4.

6

Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease.神经元中间丝包涵体病中丰富的 FUS 免疫反应性病理学。

Acta Neuropathol. 2009 Nov;118(5):605-16. doi: 10.1007/s00401-009-0581-5. Epub 2009 Aug 9.

7

Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).神经元中间丝包涵体病（NIFID）中 FUS 免疫反应性神经元细胞质包涵体（NCI）的空间模式。

J Neural Transm (Vienna). 2011 Nov;118(11):1651-7. doi: 10.1007/s00702-011-0690-x. Epub 2011 Jul 27.

8

Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.核载体和 RNA 结合蛋白在伴有肉瘤融合（FUS）病理性改变的额颞叶变性中。

Neuropathol Appl Neurobiol. 2013 Feb;39(2):157-65. doi: 10.1111/j.1365-2990.2012.01274.x.

9

Distinct pathological subtypes of FTLD-FUS.具有不同病理亚型的额颞叶痴呆-融合基因。

Acta Neuropathol. 2011 Feb;121(2):207-18. doi: 10.1007/s00401-010-0764-0. Epub 2010 Oct 30.

10

Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.运输蛋白 1 与肉瘤中融合（FUS）包涵体的共定位不是肌萎缩侧索硬化症-FUS 的特征，这证实了突变型 FUS 的核输入受到破坏，并将其与 FUS 包涵体的额颞叶变性区分开来。

Neuropathol Appl Neurobiol. 2013 Aug;39(5):553-61. doi: 10.1111/j.1365-2990.2012.01300.x.